Human astrocytic brain tumors express APO2L/TRAIL (original) (raw)

Abstract

APO2 ligand (APO2L) is a CD95 ligand (CD95L)-related cytokine of the tumor necrosis factor family that interacts with agonistic (DR4, DR5) and antagonistic (DcR1, DcR2) receptors. Cultured malignant glioma cells preferentially express agonistic receptors and are susceptible to APO2L-induced apoptosis. Here, we report that 8 of 8 human glioma cell lines expressed APO2L mRNA and protein in vitro. Immunohistochemistry using a monoclonal antibody to APO2L revealed that all 23 primary astrocytic brain tumors analyzed, including low-grade astrocytomas and glioblastomas, express APO2L in vivo. With the exception of reactive astrocytes, non-neoplastic glia and neurons in the cerebrum lacked immunoreactivity of APO2L. Thus, in addition to the CD95/CD95L system, a second death ligand/death receptor pair may regulate susceptibility to apoptosis in human glial neoplasms.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Laboratory of Molecular Neuro-Oncology, Department of Neurology, University of Tübingen, D-72 076 Tübingen, Germany e-mail: michael.weller@uni-tuebingen.de, Tel.: +49-7071-298 2141, Fax: +49-7071-29 6507, , , , , , DE
    Johannes Rieger & M. Weller
  2. International Agency for Research on Cancer (IARC), Lyon, France, , , , , , FR
    Hiroko Ohgaki & Paul Kleihues

Authors

  1. Johannes Rieger
    You can also search for this author inPubMed Google Scholar
  2. Hiroko Ohgaki
    You can also search for this author inPubMed Google Scholar
  3. Paul Kleihues
    You can also search for this author inPubMed Google Scholar
  4. M. Weller
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 19 August 1998 / Accepted: 14 September 1998

Rights and permissions

About this article

Cite this article

Rieger, J., Ohgaki, H., Kleihues, P. et al. Human astrocytic brain tumors express APO2L/TRAIL.Acta Neuropathol 97, 1–4 (1999). https://doi.org/10.1007/s004010050948

Download citation